| Trial registration number
|
NCT04623619 |
Full text link
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04623619
|
First author
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Antonio Cascio, MD, PhD
|
Contact
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
antonio.cascio03@unipa.it
|
Registration date
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
2020-11-10
|
Recruitment status
Last imported at : Nov. 7, 2022, noon
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
unclear
|
Study aim
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- positive swab test of sars-cov-2
- pneumonia related to sars-cov-2
- signature of informed consent
|
Exclusion criteria
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
- unsigned informed consent
- negative swab test of sars-cov-2
|
Number of arms
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
|
Inclusion age min
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
None
|
Type of patients
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
Moderate/severe/critical disease at enrollment
|
Severity scale
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
5: Moderate/severe/critical disease at enrollment
|
Total sample size
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
100
|
primary outcome
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
In-hospital mortality
|
Notes
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Nov. 11, 2020, 11:31 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 19, "treatment_name": "Acetyl l-carnitine", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|